Dr Kelly Newell
BSc (Hons), PhD
Position:
Teaching and Coordinating:
- BMS346 Motor Control and Dysfunction
- Honours and postgraduate research student supervision
Research Interests:
My research focuses on using post-mortem human brain tissue and animal models to investigate possible causes of schizophrenia. Specifically I am interested in the role of the glutamatergic system, especially the NMDA receptor, in the aetiology of schizophrenia, and how disruptions to this system affects other brain systems especially the endogenous cannabinoid system and the cholinergic system. I am also interested in the role of the neuregulin1-ErbB4 signaling pathway in schizophrenia and how this system interacts with the glutamatergic system.
Publications:
Searchable RIS publications from 2000 to date.
Newell, K.A., Zavitsanou, K., and Huang, X.F. 2007. Short and Long-term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment. Journal of Neural Transmission, 114: 995-1001.
Newell, K.A., Zavitsanou, K., and Huang, X.F. 2007. Opposing short and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment. Journal of Neuroscience Research, 85:1358-1363.
Newell, K.A., Zavitsanou, K., Kum-Jew, S., and Huang, X.F. 2007. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Progress in Neuropsychopharmacology & Biological Psychiatry, 31:225-233.
Newell, K.A., Deng, C., and Huang, X.F. 2006. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Experimental Brain Research, 172: 556-560.
Newell, K.A., Zavitsanou, K., and Huang, X.F. 2005. Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients. NeuroReport, 16: 1363-1367.
|
|
